Catalyst Wire Dossier Catalyst Wire Dossier

Brelovitug

BJT-778
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Brelovitug, covering 2026-03-02 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide [Phase 2, Phase 3]

See pricing